Slate Auto , the EV startup backed by Jeff Bezos, raised $650 million to fund its effort to build an affordable electric pickup truck expected to start in the mid-$20,000s. The company plans on delivering its first EV later this year. The Series C round was led by TWG Global, headed by Guggenheim Partners founder and LA Dodgers owner Mark Walter and financier Thomas Tull. Slate didn't disclose its...
Slate Auto , the EV startup backed by Jeff Bezos, raised $650 million to fund its effort to build an affordable electric pickup truck expected to start in the mid-$20,000s. The company plans on delivering its first EV later this year. The Series C round was led by TWG Global, headed by Guggenheim Partners founder and LA Dodgers owner Mark Walter and financier Thomas Tull. Slate didn't disclose its latest investors, but both Walter and Tull were investors in Re:Build Manufacturing, a Bezos-owned company from which Slate spun off last year . The company also didn't disclose its latest valuation, but was at $1.2 billion as of January 2025, acco … Read the full story at The Verge.
Shutter2U/iStock via Getty Images Strategy Direxion NASDAQ-100 Equal Weighted Index Shares ETF ( QQQE ) was launched on 3/21/2012 and tracks the NASDAQ-100 ® Equal Weighted Index. QQQE has a portfolio of 101 stocks, a 12-month trailing yield of 0.63% and an expense ratio of 0.35%. As described by Direxion , the underlying index is the equal weighted version of the NASDAQ-100 Index ® , which includ...
Shutter2U/iStock via Getty Images Strategy Direxion NASDAQ-100 Equal Weighted Index Shares ETF ( QQQE ) was launched on 3/21/2012 and tracks the NASDAQ-100 ® Equal Weighted Index. QQQE has a portfolio of 101 stocks, a 12-month trailing yield of 0.63% and an expense ratio of 0.35%. As described by Direxion , the underlying index is the equal weighted version of the NASDAQ-100 Index ® , which includes approximately 100 of the largest non-financial companies listed on the NASDAQ stock exchange, based on market capitalization. The index is reconstituted annually in December and rebalanced quarterly, but replacements may be made any time. The fund’s turnover rate in the most recent fiscal year was 33%. I will use as a benchmark Invesco QQQ Trust ( QQQ ). Portfolio The fund is quite balanced in large/mega cap companies (about 54% of asset value) and mid-caps (46%), while the cap-weighted index has about 88% in large/mega caps. Information technology is by far the heaviest sector in the portfolio (39.7%), but not as heavy as in QQQ (50.4%). Compared to the benchmark, QQQE mostly overweights industrials and healthcare. While it downplays technology and communication. QQQE sector breakdown in % of assets (Chart: author: data: Direxion) Due to its weighting methodology, the fund has low company-specific risk. The current top 10 holdings, listed in the next table, represent only 11.8% of asset value, compared to 46.8% in QQQ. These are the constituents with the highest price return since the most recent rebalance. Ticker Name Weight% INTC INTEL CORP 1.36 MRVL MARVELL TECHNOLOGY INC 1.32 MPWR MONOLITHIC POWER SYSTEMS INC 1.21 STX SEAGATE TECHNOLOGY HOLDINGS 1.18 AMD ADVANCED MICRO DEVICES 1.14 INSM INSMED INC 1.14 FER FERROVIAL SE 1.12 WDC WESTERN DIGITAL CORP 1.12 KLAC KLA CORP 1.12 TXN TEXAS INSTRUMENTS INC 1.11 Click to enlarge The equal-weight methodology is applied at issuer level, not at security level. Indeed, both share series of Alphabet Inc ( GOOGL and GOOG ) are in t...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. Stock indexes are mixed this morning even as crude oil prices surge after President...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. Stock indexes are mixed this morning even as crude oil prices surge after President...
hxdbzxy/iStock via Getty Images As Q1 2026 earnings season gets underway, the Information Technology sector enters reporting season as one of the most closely watched, and highest-expectation, areas of the market. This list ranks large-cap Information Technology stocks that have earned an A+ EPS revision grade from Seeking Alpha’s Quant rating system. The screening criteria include stocks within t...
hxdbzxy/iStock via Getty Images As Q1 2026 earnings season gets underway, the Information Technology sector enters reporting season as one of the most closely watched, and highest-expectation, areas of the market. This list ranks large-cap Information Technology stocks that have earned an A+ EPS revision grade from Seeking Alpha’s Quant rating system. The screening criteria include stocks within the IT sector with large market capitalizations and the highest possible EPS revision grade. The list includes Ciena Corporation ( CIEN ), a communications equipment company with a market cap of $70.14 billion. Coherent Corp. ( COHR ) and Dell Technologies Inc. ( DELL ) follow, with Dell notably carrying a Strong Buy Quant rating of 4.94 alongside its A+ EPS revision grade. The list features a diverse range of IT industries, including communications equipment, semiconductors, electronic manufacturing services, and application software. All 12 companies maintain the highest A+ EPS revision grade, with two stocks—Dell Technologies Inc. ( DELL ) and TTM Technologies, Inc. ( TTMI )—also earning Strong Buy Quant ratings. Ciena Corporation ( CIEN ) EPS revision grade: A+ Coherent Corp. ( COHR ) EPS revision grade: A+ Dell Technologies Inc. ( DELL ) EPS revision grade: A+ F5, Inc. ( FFIV ) EPS revision grade: A+ Flex Ltd. ( FLEX ) EPS revision grade: A+ HubSpot, Inc. ( HUBS ) EPS revision grade: A+ MKS Inc. ( MKSI ) EPS revision grade: A+ Monolithic Power Systems, Inc. ( MPWR ) EPS revision grade: A+ Strategy Inc ( MSTR ) EPS revision grade: A+ MACOM Technology Solutions Holdings, Inc. ( MTSI ) EPS revision grade: A+ TD SYNNEX Corporation ( SNX ) EPS revision grade: A+ TTM Technologies, Inc. ( TTMI ) EPS revision grade: A+ Tech ETFs: ( VGT ), ( XLK ), ( IYW ), ( FTEC ), ( IXN ), and ( RSPT ) More on IT stocks 6 Themes For Earning Season IXN: Global Tech Leadership Remains, Eyeing A New Record High The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The AI boom ...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
Amazon stock has been one of the strongest names in the "Magnificent Seven" since the broader market's March 30 low. But after a sharp three-day surge, its rally is now running into an area that has repeatedly stopped it before.
Amazon stock has been one of the strongest names in the "Magnificent Seven" since the broader market's March 30 low. But after a sharp three-day surge, its rally is now running into an area that has repeatedly stopped it before.
Midfielder faces seven charges of rape in total Judge says trial may be delayed until early next year The former Arsenal midfielder Thomas Partey has pleaded not guilty to two new allegations of rape. The 32-year-old appeared at Southwark crown court on Monday to deny raping a woman twice in London on a single day in December 2020. Partey, who left Arsenal for Villarreal last summer, was charged i...
Midfielder faces seven charges of rape in total Judge says trial may be delayed until early next year The former Arsenal midfielder Thomas Partey has pleaded not guilty to two new allegations of rape. The 32-year-old appeared at Southwark crown court on Monday to deny raping a woman twice in London on a single day in December 2020. Partey, who left Arsenal for Villarreal last summer, was charged in July last year with five counts of rape and one allegation of sexual assault, dating back to 2021 and 2022. He previously pleaded not guilty to those charges and a trial was set for November this year. Continue reading...
Microsoft is looking into ways it can integrate OpenClaw-style features into 365 Copilot, according to a report from The Information . The test reportedly comes as part of efforts to make its 365 Copilot AI assistant "run autonomously around the clock" while completing tasks on behalf of users. Omar Shahine, Microsoft's corporate vice president, confirmed to The Information that the company is "ex...
Microsoft is looking into ways it can integrate OpenClaw-style features into 365 Copilot, according to a report from The Information . The test reportedly comes as part of efforts to make its 365 Copilot AI assistant "run autonomously around the clock" while completing tasks on behalf of users. Omar Shahine, Microsoft's corporate vice president, confirmed to The Information that the company is "exploring the potential of technologies like OpenClaw in an enterprise context." OpenClaw is an open-source platform that allows users to create AI-powered agents that run locally on a user's device. The platform rose in popularity earlier this year, … Read the full story at The Verge.
If it’s time for you to upgrade your phone, it’s worth considering the Pixel 10A , Google’s latest midrange phone that has some (but not all) of the new software features of the pricier $599 Pixel 10. Every color of the 128GB 10A — including the alluring “berry” tone — is down to $449 ($50 off) at Amazon , Best Buy , and the Google Store , where you can get it for even less with an eligible trade-...
If it’s time for you to upgrade your phone, it’s worth considering the Pixel 10A , Google’s latest midrange phone that has some (but not all) of the new software features of the pricier $599 Pixel 10. Every color of the 128GB 10A — including the alluring “berry” tone — is down to $449 ($50 off) at Amazon , Best Buy , and the Google Store , where you can get it for even less with an eligible trade-in. This is the first cash discount we’ve seen since the phone’s launch in early March. The 256GB version is $50 off, too, selling for $549 at Amazon and Best Buy . Google Pixel 10A Where to Buy: $499 $449 at Amazon (128GB) $499 $449 at Best Buy (128GB) $599 $549 at Amazon (256GB) If you look at our coverage of the Pixel 10A , it won’t take you long to put the pieces together and see that we feel Google played it safe with this year’s model. It’s strikingly similar to last year’s Pixel 9A — both feature a Tensor G4 processor, plus a camera combo consisting of a 48-megapixel main shooter and a 13-megapixel ultrawide lens — but we don’t suggest getting the 9A, right now at least. Its software support will end a year earlier, and it’s currently more expensive than the 10A ($50 more at most retailers). The 10A stands out for its slightly brighter screen, faster wired charging, and support for Satellite SOS, among other small differences. It also has two unique AI-powered features from the Pixel 10 series that are not available on the 9A: Camera Coach and Auto Best Take. However, there are no internal hardware differences in the latest version that would prevent the features from coming to last year’s model. Read our full Pixel 10A review . Some more Verge -approved deals Sony’s WF-1000XM6 are back down to around $298 at Amazon and Best Buy , matching their lowest price to date. The wireless, noise-canceling earbuds debuted in mid-February at $329, and they were discounted to this price once before, in the latter half of March. My colleague John Higgins praised their stellar sou...
Shareholders of Compass Diversified (Symbol: CODI) looking to boost their income beyond the stock's 9.8% annualized dividend yield can sell the January 2027 covered call at the $15 strike and collect the premium based on the $1.60 bid, which annualizes to an additional 20.8% rat
Shareholders of Compass Diversified (Symbol: CODI) looking to boost their income beyond the stock's 9.8% annualized dividend yield can sell the January 2027 covered call at the $15 strike and collect the premium based on the $1.60 bid, which annualizes to an additional 20.8% rat
Federal Court Strikes Down 158-Year-Old Home Distilling Ban Authored by Kimberly Hayek via The Epoch Times (emphasis ours), A federal appeals court on April 10 declared a nearly 158-year-old ban on home distilling to be unconstitutional , ruling that the ban was an unnecessary and improper means for Congress to exercise its power to tax. A judge's gavel rests on top of a desk in a courtroom in Mia...
Federal Court Strikes Down 158-Year-Old Home Distilling Ban Authored by Kimberly Hayek via The Epoch Times (emphasis ours), A federal appeals court on April 10 declared a nearly 158-year-old ban on home distilling to be unconstitutional , ruling that the ban was an unnecessary and improper means for Congress to exercise its power to tax. A judge's gavel rests on top of a desk in a courtroom in Miami on Feb. 3, 2009. Joe Raedle/Getty Images Writing for a three-judge panel in McNutt v. U.S. Department of Justice, Judge Edith Hollan Jones of the U.S. Court of Appeals for the Fifth Circuit found that the ban actually reduced tax revenue by preventing distilling in the first place, the opposite of its stated intent. The court ruled in favor of the nonprofit Hobby Distillers Association and four of its 1,300 members, who argued that people should be free to distill spirits at home, whether as a hobby or for personal consumption—including, for instance, to create an apple pie vodka recipe one of the plaintiffs created. The ban was part of a law passed during Reconstruction in July 1868. It imposed excise taxes on distilled spirits but also made it illegal for a person to use “any still, boiler, or other vessel for purpose of distilling” when the still was located, among other places, “in any dwelling-house” or “in any shed, yard, or enclosure connected with any dwelling-house.” The case began in December 2023 when the Competitive Enterprise Institute, a libertarian think tank, filed suit on behalf of the Hobby Distillers Association and four individuals against the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau and the Department of Justice. The hobby group argued that the government’s regulatory reach could not extend to activities within a person’s home. The face of the case was Scott McNutt, a New Jersey resident and former U.S. Coast Guard engineer. McNutt received an unsolicited letter from the Alcohol and Tobacco Tax and Trade Bureau warning him of po...
In early trading on Monday, shares of Applovin topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Applovin has lost about 39.8% of its value. And the worst performing Nasdaq 100 component thus far on the day is CoSta
In early trading on Monday, shares of Applovin topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Applovin has lost about 39.8% of its value. And the worst performing Nasdaq 100 component thus far on the day is CoSta
simona flamigni/iStock Editorial via Getty Images In this article, I'll be providing an update on BNP Paribas ( BNPQF ), an investment I had over a year ago. It was part of a major set of investments in European banking when those banks, including BNP, were underappreciated and, in my view, undervalued. Not only did I make good returns from BNP Paribas, but also from Société Générale ( SCGLY ) and...
simona flamigni/iStock Editorial via Getty Images In this article, I'll be providing an update on BNP Paribas ( BNPQF ), an investment I had over a year ago. It was part of a major set of investments in European banking when those banks, including BNP, were underappreciated and, in my view, undervalued. Not only did I make good returns from BNP Paribas, but also from Société Générale ( SCGLY ) and from Credit Agricole ( CRARY ). However, I sold all of those positions over a year ago, and I reinvested the capital into other companies. For the most part, I'm happy with the decision to do that. While some of the banks have seen some outperformance relative to the SPY, up about 9% since my last article on BNP Paribas, found here, the investments I've made are mostly more attractive than it would have been (in my view) to keep BNP in my portfolio. Of course, there are probably those who kept BNP in their portfolio, and those have also done well if holding on to this bank until now. Despite the significant decline during the fall of last year, BNP has come back in early 2026 and is currently trading at what I would consider a relatively high valuation. This begs the question if the company should be viewed as a target for rotation here. Trading at a native price target of about €90/share may not be viewed as very expensive given a relatively low P/E, relatively good fundamentals, and a decent dividend, but there are risks to this bank that should not be underestimated in the long term. The current targets and forecasts are for the bank to grow an average of double digits in EPS over the next three years. I have previously covered both regional and multinational banks with similar growth profiles and forecasts and cited those as being unrealistic. In my Investing Group, Wolf of Value , I cover other financials and banks similar to BNP Paribas that I consider to be more attractive than this one, as well as other interesting investments for both conservative, income-oriented...
Netflix heads into Q1 earnings with 15% revenue growth, rising ad momentum and stronger content deals, positioning NFLX as a compelling buy ahead of results.
Netflix heads into Q1 earnings with 15% revenue growth, rising ad momentum and stronger content deals, positioning NFLX as a compelling buy ahead of results.
Carolina Rudah/iStock via Getty Images Novo Nordisk A/S ( NVO ) is a multinational pharmaceutical company best known for Wegovy and Ozempic, GLP-1 drugs best known for revolutionizing weight loss. Despite that, the company's share price has dropped substantially, with continued weakness since we recommended catching the falling knife, impacted by increased competition and generics in a promising m...
Carolina Rudah/iStock via Getty Images Novo Nordisk A/S ( NVO ) is a multinational pharmaceutical company best known for Wegovy and Ozempic, GLP-1 drugs best known for revolutionizing weight loss. Despite that, the company's share price has dropped substantially, with continued weakness since we recommended catching the falling knife, impacted by increased competition and generics in a promising market. Despite that, Novo Nordisk has an impressive portfolio of drugs under development and financials that make the company a valuable investment. Novo Nordisk 2025 Highlights Novo Nordisk managed to have a strong 2025 despite growing competition, with 10% sales growth and 6% operating profit growth. Novo Nordisk Investor Presentation Novo Nordisk managed to have a massive, almost $5 billion USD in FCF and almost double that in shareholder returns. Despite continued investments, the company also has a 4.8% dividend yield that it can comfortably afford in our view. The erosion of market share is clearly visible, with a 3.6% decline, but the growth in the market resulted in strong obesity care sales growth. Additionally, Novo Nordisk has continued to put together a strong alternative portfolio, with 9% rare disease sales growth. Novo Nordisk is continuing to raise the bar for innovation and has an exciting portfolio of upcoming opportunities. Novo Nordisk Investor Presentation Novo Nordisk continues to earn the lion's share of its revenue from the United States with the growth of GLP-1 drugs. However, international operations saw faster growth (almost double the rate of the US), indicating the company's continued diversification. At the same time, Novo Nordisk continues to see strong growth in obesity care and rare diseases, even if GLP-1 growth slows. Novo Nordisk Investor Presentation It's worth noting here that the GLP-1 market might be seeing substantial competition; however, rapid growth in the market itself is making up for that. In the international market, Ozempic r...